Management of peripheral arterial disease and intermittent claudication
- PMID: 11757887
Management of peripheral arterial disease and intermittent claudication
Abstract
Background: Peripheral arterial disease (PAD) is the chronic obstruction of the arteries supplying the lower extremities. The most common symptom is intermittent claudication resulting in aching pain, numbness, weakness, or fatigue in the muscle groups of the lower extremities.
Methods: Using the key words "peripheral arterial disease," "intermittent claudication," "atherosclerosis," and "cardiovascular disease," MEDLINE databases were searched from 1970 to the present. The most recent articles pertinent to current treatment recommendations for PAD and intermittent claudication were selected to document this review.
Results and conclusions: Symptoms of intermittent claudication are induced by walking or exercise and usually resolve with rest. Disease severity varies from patients who are asymptomatic to those who have unremitting symptoms. A high overlap exists between PAD and coronary artery and cerebrovascular disease. Risks for long-term morbidity and mortality are identical for PAD, intermittent claudication, and coronary artery disease. Treatment of PAD is aimed at maintaining or improving functional status, reducing or eliminating ischemic symptoms, and preventing disease progression. Exercise and aggressive risk factor modification represent the cornerstones of treatment. Risk factors include smoking, diabetes, lipid abnormalities, hypertension, C-reactive protein, lipoprotein(a), and hyperhomocystinemia. Antiplatelet and lipid-altering therapies decrease risk of atherosclerotic vascular complications and are being studied to improve intermittent claudication. Cilostazol, a new antiplatelet, antithrombotic agent, reduces claudication symptoms. Angiogenic growth factors have shown preliminary success in patients with rest pain and ischemic ulcers and are being investigated for use in patients with intermittent claudication. Invasive revascularization procedures can be considered for patients with critical limb ischemia or when medical therapy fails.
Similar articles
-
Pharmacological interventions for peripheral artery disease.Expert Opin Pharmacother. 2007 Jul;8(10):1465-77. doi: 10.1517/14656566.8.10.1465. Expert Opin Pharmacother. 2007. PMID: 17661729 Review.
-
Intermittent claudication due to peripheral artery disease: best modern medical and endovascular therapeutic approaches.Curr Cardiol Rep. 2015 Oct;17(10):86. doi: 10.1007/s11886-015-0643-3. Curr Cardiol Rep. 2015. PMID: 26280273 Review.
-
Peripheral artery disease: therapeutic advances.Expert Rev Cardiovasc Ther. 2008 Apr;6(4):539-53. doi: 10.1586/14779072.6.4.539. Expert Rev Cardiovasc Ther. 2008. PMID: 18402543 Review.
-
Management of peripheral arterial disease.Cardiol Rev. 2005 Mar-Apr;13(2):61-8. doi: 10.1097/01.crd.0000126082.86717.12. Cardiol Rev. 2005. PMID: 15705252 Review.
-
Peripheral arterial disease in women.Maturitas. 2009 Dec 20;64(4):204-11. doi: 10.1016/j.maturitas.2009.10.001. Epub 2009 Oct 22. Maturitas. 2009. PMID: 19853389 Review.
Cited by
-
The reliability of differentiating neurogenic claudication from vascular claudication based on symptomatic presentation.Can J Surg. 2013 Dec;56(6):372-7. doi: 10.1503/cjs.016512. Can J Surg. 2013. PMID: 24284143 Free PMC article.
-
Connective tissue reflex massage for type 2 diabetic patients with peripheral arterial disease: randomized controlled trial.Evid Based Complement Alternat Med. 2011;2011:804321. doi: 10.1093/ecam/nep171. Epub 2011 Mar 13. Evid Based Complement Alternat Med. 2011. PMID: 19933770 Free PMC article.
-
Avascular Necrosis of Bone following Chemotherapy in Cancer Patients with Coagulopathy: Report of Two Cases.Case Rep Oncol. 2018 Mar 27;11(1):185-190. doi: 10.1159/000488102. eCollection 2018 Jan-Apr. Case Rep Oncol. 2018. PMID: 29681819 Free PMC article.
-
Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.J Appl Biomech. 2012 May;28(2):184-91. doi: 10.1123/jab.28.2.184. J Appl Biomech. 2012. PMID: 22723116 Free PMC article. Clinical Trial.
-
The Different Facets of Dyslipidemia and Hypertension in Atherosclerosis.Curr Atheroscler Rep. 2016 Dec;18(12):82. doi: 10.1007/s11883-016-0632-z. Curr Atheroscler Rep. 2016. PMID: 27822682 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials